These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2143731)

  • 1. Role of the adrenal gland in the metabolic and cardiovascular effects of 8-OH-DPAT in the rat.
    Bouhelal R; Mir AK
    Eur J Pharmacol; 1990 May; 181(1-2):89-95. PubMed ID: 2143731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the adrenal medulla in the metabolic and pressor actions of 8-OH-DPAT.
    Bouhelal R; Mir AK
    Br J Pharmacol; 1992 Jan; 105(1):159-63. PubMed ID: 1534503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the mechanism(s) of 8-OH-DPAT-mediated inhibition of plasma insulin in spontaneously hypertensive rats.
    Bouhelal R; Loubatières-Mariani MM; Mir AK
    Br J Pharmacol; 1990 May; 100(1):173-9. PubMed ID: 2142614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.
    Fozard JR; Mir AK; Middlemiss DN
    J Cardiovasc Pharmacol; 1987 Mar; 9(3):328-47. PubMed ID: 2437400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between the cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) and clonidine in the conscious sino-aortic denervated rat.
    Petty MA; Kintz J; Di Francesco GF; Fozard JR
    J Auton Pharmacol; 1988 Dec; 8(4):267-76. PubMed ID: 2855330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperinsulinemia of the genetically obese (fa/fa) rat is decreased by a low dose of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Chaouloff F; Jeanrenaud B
    Eur J Pharmacol; 1988 Feb; 147(1):111-8. PubMed ID: 2967189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marked increases in plasma catecholamine concentrations precede hypotension and bradycardia caused by 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in conscious rats.
    Bagdy G; Szemeredi K; Murphy DL
    J Pharm Pharmacol; 1989 Apr; 41(4):270-2. PubMed ID: 2568470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and adrenaline-releasing effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin in streptozotocin diabetic rats.
    Chaouloff F; Blanc J; Baudrie V; Laude D; Elghozi JL
    Life Sci; 1991; 48(26):2543-52. PubMed ID: 1828521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
    Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
    Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that 5-HT1A receptors are involved in the adrenaline-releasing effects of 8-OH-DPAT in the conscious rat.
    Chaouloff F; Baudrie V; Laude D
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):381-4. PubMed ID: 1970616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypotensive action of 8-hydroxy-2-(di-N-propylamino)tetralin (8-OH-DPAT) in spontaneously hypertensive rats.
    Martin GE; Lis EV
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):251-61. PubMed ID: 3159366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentobarbital anaesthesia prevents the adrenaline-releasing effect of the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin.
    Chaouloff F; Baudrie V; Laude D
    Eur J Pharmacol; 1990 May; 180(1):175-8. PubMed ID: 2142092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects following injection of 8-OH-DPAT and flesinoxan into the dorsal raphe nucleus of conscious rats.
    Connor HE; Higgins GA
    Br J Pharmacol; 1989 Dec; 98 Suppl():810P. PubMed ID: 2532943
    [No Abstract]   [Full Text] [Related]  

  • 16. 8-OH-DPAT increases corticosterone but not other 5-HT1A receptor-dependent responses more in females.
    Haleem DJ; Kennett GA; Whitton PS; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):435-43. PubMed ID: 2527755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chronic treatment on the cardiovascular and behavioral responses of 8-OH-DPAT in conscious normotensive rats.
    Kolbasa KP; McCall RB; Ludens JH
    Eur J Pharmacol; 1991 Feb; 193(3):275-81. PubMed ID: 1829040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in conscious dogs.
    Di Francesco GF; Petty MA; Fozard JR
    Eur J Pharmacol; 1988 Mar; 147(2):287-90. PubMed ID: 2966743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenalectomy does not prevent the ability of 8-OH-DPAT to decrease the ejaculatory threshold in male rats.
    Vega-Matuszczyk J; Ahlenius S; Eneroth P; Larsson K
    Eur Neuropsychopharmacol; 1995 Jun; 5(2):115-8. PubMed ID: 7549453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K; Ahlenius S; Alster P; Hillegaart V
    Neuroendocrinology; 1996 Mar; 63(3):269-74. PubMed ID: 8677015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.